Publication | Open Access

Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists

BiochemistryMedicineRational Drug DesignMechanism Of ActionPharmacological AgentPharmacotherapy-Benzoxazin-3-one DerivativesDrug DevelopmentPharmacologyDrug Discovery